Navigation Links
Surgeon General's 'Call to Action' to Prevent DVT/PE Praised by NATT as Turning Point
Date:9/15/2008

TARRYTOWN, N.Y., Sept. 15 /PRNewswire-USNewswire/ -- The National Alliance for Thrombosis and Thrombophilia (NATT) praised Acting Surgeon General Rear Admiral Steven K. Galson, MD, MPH for issuing an historic "Call to Action" (CTA) to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE).

RADM Galson presented the CTA this morning in Washington DC (http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action- on-dvt-2008.pdf ). Dr. Galson called for "the development of a coordinated strategy to improve awareness of DVT and PE," pointing out that blood clots "contribute to at least 100,000 deaths each year."

"Today will be forever remembered as the turning point in the battle against blood clots," said NATT President Randy Fenninger. "NATT is committed to working aggresively to build on the momentum of this important CTA.

NATT is executing a strategic plan of awareness and education (consumers, patients and health professionals), outreach, advocacy and support towards achieving the goals of the CTA.

Blood clots are far more frequent than most people understand because they are often secondary to other other underlying illnesses or conditions. For example, some of those most vulnerable to DVT/PEs include people being hospitalized, undergoing major surgery (e.g. hip or knee replacement) or living in nursing homes. Others at risk include people with cancer, travellers on long trips (e.g. train, airplane), older age, obesity, women on hormone replacement therapy, birth control (pills, patch, ring) or pregnancy/recently gave birth or genetic/hereditary or acquired blood clotting disorder.

NATT Medical Director Stephan Moll, MD said "the CTA underscores the public health urgency of preventing the hundreds of thousands of deaths and DVT/PEs that occur each year."

In cooperation with the Centers for Disease Control, NATT will be convening "Stop the Clot Forums" for patient and consumer education:

-- October 4 - Minneapolis, MN

http://www.stoptheclot.org/Trifold_self-mail_wForm_v1-2.pdf

-- October 18 - Baltimore, MD

-- November 22 - Raleigh-Durham, NC

In the past year, CDC has designated thrombosis as a priority, increasing surveillance of DVT/PE in the US and entering into a cooperative agreement with NATT to educate patients, the public and healthcare professionals. In August, The Center for Medicare and Medicaid Services issued final regulations that recognizes DVT/PE as Hospital Acquired Conditions for patients undergoing hip/knee replacement surgery because, with proper prophylaxis, DVT/PE can be prevented most of the time.

Contact:

Alan Brownstein

914.220.5040


'/>"/>
SOURCE National Alliance for Thrombosis and Thrombophilia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs
2. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
3. Got Fat?: Plastic Surgeons Review Fat-Melting and Fat-Grafting Procedures
4. Miami Plastic Surgeon Offers Hope to Acne Scarred Patients
5. Surgeons Develop Innovative Life-Saving Treatments to Correct Massive Bleeding in Trauma Patients
6. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
7. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
8. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
9. High Intensity Focused Ultrasound for Locally Recurrent Prostate Cancer Following External Beam Radiation Therapy Investigated in Phase III Clinical Study
10. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
11. Novavax to Present Phase I/IIa Trial Data Results in an Investor Conference Call on August 26, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... , Sept. 25, 2017   Montrium , ... File solutions, today—from the IQPC Trial Master Files ... , NL)—announced that EastHORN Clinical Services has selected ... programs and TMF management. EastHORN, a leading European ... platform to increase transparency to enable greater collaboration ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
(Date:10/12/2017)... , ... October 12, 2017 , ... Planet Fitness, one ... U.S., announced today its plans to open a flagship location in Covington, LA at ... former Rooms To Go store next to Office Depot in the Holiday Square shopping ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):